See more : L’Air Liquide S.A. (AI.VI) Income Statement Analysis – Financial Results
Complete financial analysis of PowerUp Acquisition Corp. (PWUP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PowerUp Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Teléfonos de México, S.A.B. de C.V. (TMXLF) Income Statement Analysis – Financial Results
- JAPAN POST BANK Co., Ltd. (JPSTF) Income Statement Analysis – Financial Results
- XY Labs, Inc. (XYLB) Income Statement Analysis – Financial Results
- BlackRock Capital Investment Corporation (0HO6.L) Income Statement Analysis – Financial Results
- CCS Supply Chain Management Co., Ltd. (600180.SS) Income Statement Analysis – Financial Results
PowerUp Acquisition Corp. (PWUP)
Industry: Shell Companies
Sector: Financial Services
About PowerUp Acquisition Corp.
PowerUp Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business within the interactive media, digital media, sports, entertainment, and/or leisure areas. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.34M | 976.35K | 27.79K |
| Selling & Marketing | 0.00 | 0.00 | 25.45K |
| SG&A | 1.34M | 976.35K | 25.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.34M | 976.35K | 25.48K |
| Cost & Expenses | 1.34M | 976.35K | 25.48K |
| Interest Income | 5.81M | 4.32M | 0.00 |
| Interest Expense | 8.97K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.34M | 976.35K | 27.79K |
| EBITDA | 5.80M | 4.32M | -25.48K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.34M | -5.29M | -25.48K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 5.80M | 4.32M | 5.00 |
| Income Before Tax | 4.46M | 3.34M | -25.48K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -4.32M | -27.79 |
| Net Income | 4.46M | 7.66M | -25.48K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.23 | 0.21 | 0.00 |
| EPS Diluted | 0.23 | 0.21 | 0.00 |
| Weighted Avg Shares Out | 19.18M | 35.94M | 6.25M |
| Weighted Avg Shares Out (Dil) | 19.18M | 35.94M | 6.25M |
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP and ESGR
NEW YORK , Oct. 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are...
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of PWUP, ESGR
NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services...
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million. Industry-Leading Platform: Aspire is focused on developing a pipeline of products utilizing its novel delivery mechanisms to enhance the efficacy of “do no...
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq: PWUP), a Nasdaq Global Market® listed...
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that, on June 3, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that the...
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
New York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP) announced today that its extraordinary general meeting of shareholders (the “Meeting”), which was originally scheduled for May 17, 2024 and postponed to May 21,...
Source: https://incomestatements.info
Category: Stock Reports